Old targets, new strategy: apigenin-7-O-beta-d-(-6-p-coumaroyl)-glucopyranoside prevents endothelial ferroptosis and alleviates intestinal ischemia-reperfusion injury through HO-1 and MAO-B inhibition
Key Points Tirzepatide and Ozempic are two leading GLP-1 medications
Other concerning risks include intestinal blockages, pancreatitis, and rare but severe gallbladder complications such as cholecystitis (inflammation)
Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management in adults with obesity or overweight with weight-related comorbidities
By modulating these three critical metabolic axes, Retatrutide effectively neutralizes the triggers of excessive caloric intake and sluggish lipid oxidation
Take the Next Step Toward Your Goals If you are ready to explore a new approach to weight loss and wellness, peptide therapy may be an option worth considering